| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-100 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-103 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-106a | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-106b | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-107 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-10a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-125a | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-125b | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-127 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-128b | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-130a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-132 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-133a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-133b | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-140 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-141 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-145 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-146b | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-148a | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-149 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-152 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-155 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-15a | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-15b | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-16 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-17 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-181b | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-181d | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-182 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-185 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-186 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-187 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-18a | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-18b | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-191 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-192 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-193b | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-194 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-195 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-196b | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-199a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-199a* | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-1 | Doxorubicin (Adriamycin) | lung cancer | Sensitive | Low | 18818206 | |
| miR-100 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18971180 | |
| miR-106a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18971180 | |
| miR-106b | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18971180 | |
| miR-108a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18971180 | |
| miR-125a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18971180 | |
| miR-125b | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18971180 | |
| miR-130a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18971180 | |
| miR-141 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18971180 | |
| miR-155 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18971180 | |
| miR-183 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18971180 | |
| miR-193a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18971180 | |
| miR-106a | Doxorubicin (Adriamycin) | ovarian cancer | Resistant | High | 19237188 | |
| miR-126 | Doxorubicin (Adriamycin) | ovarian cancer | Resistant | High | 19237188 | |
| miR-132 | Doxorubicin (Adriamycin) | ovarian cancer | Resistant | High | 19237188 | |
| miR-142 | Doxorubicin (Adriamycin) | ovarian cancer | Resistant | High | 19237188 | |
| miR-181a | Doxorubicin (Adriamycin) | ovarian cancer | Resistant | High | 19237188 | |
| miR-181a | Doxorubicin (Adriamycin) | ovarian cancer | Sensitive | High | 19237188 | |
| miR-1 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 19412672 | |
| miR-100 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 19412672 | |
| miR-101* | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 19412672 | |
| miR-10a | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 19412672 | |
| miR-10b | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 19412672 | |
| miR-125b-1* | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 19412672 | |
| miR-128a | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 19412672 | |
| miR-128b | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 19412672 | |
| miR-130b* | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 19412672 | |
| miR-132 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 19412672 | |
| miR-135a | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 19412672 | |
| miR-135b | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 19412672 | |
| miR-140 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-141 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-141* | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-142 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-143* | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-145 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-146a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-146b | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-148a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-151 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-153 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-154* | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-155 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-15a* | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-15b* | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-16 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-181a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-181a* | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-181c | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-181d | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-182* | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-186 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-18a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-190 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-192* | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-193a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-196a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-196b | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-199a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-199b | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-19a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-19b | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-19b-1* | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-155 | Doxorubicin (Adriamycin) | colorectal cancer | Sensitive | Low | 19458054 | |
| miR-122 | Doxorubicin (Adriamycin) | hepatocarcinoma | Sensitive | Low | 19584283 | |
| miR-181b | Doxorubicin (Adriamycin) | hepatocellular carcinoma | Resistant | Low | 20023698 | |
| miR-125a | Doxorubicin (Adriamycin) | small cell lung cancer | Sensitive | High | 20371173 | |
| miR-127 | Doxorubicin (Adriamycin) | small cell lung cancer | Sensitive | High | 20371173 | |
| miR-134 | Doxorubicin (Adriamycin) | small cell lung cancer | Sensitive | High | 20371173 | |
| miR-143 | Doxorubicin (Adriamycin) | small cell lung cancer | Sensitive | High | 20371173 | |
| miR-145 | Doxorubicin (Adriamycin) | small cell lung cancer | Sensitive | High | 20371173 | |
| miR-195 | Doxorubicin (Adriamycin) | small cell lung cancer | Sensitive | High | 20371173 | |
| miR-155 | Doxorubicin (Adriamycin) | breast cancer | Resistant | Low | 20371610 | |
| miR-199a | Doxorubicin (Adriamycin) | hepatocarcinoma | Sensitive | Low | 20501828 | |
| miR-199a | Doxorubicin (Adriamycin) | hepatocellular carcinoma | Sensitive | Low | 21055388 | |
| miR-155 | Doxorubicin (Adriamycin) | leukemia | Resistant | High | 21122348 | |
| miR-181a | Doxorubicin (Adriamycin) | leukemia | Sensitive | High | 21122348 | |
| miR-145 | Doxorubicin (Adriamycin) | esophageal cancer | Resistant | High | 21248297 | |
| miR-122 | Doxorubicin (Adriamycin) | hepatocellular carcinoma | Sensitive | Low | 21750653 | |
| miR-122 | Doxorubicin (Adriamycin) | hepatocellular carcinoma | Sensitive | Low | 21802841 | |
| miR-125b | Doxorubicin (Adriamycin) | pediatric acute promyelocytic leukemia | Resistant | Low | 21880154 | |
| miR-125b | Doxorubicin (Adriamycin) | ehrlich ascites tumor | Sensitive | High | 21899346 | |
| miR-135b | Doxorubicin (Adriamycin) | ehrlich ascites tumor | Sensitive | High | 21899346 | |
| miR-141 | Doxorubicin (Adriamycin) | ehrlich ascites tumor | Sensitive | High | 21899346 | |
| miR-182 | Doxorubicin (Adriamycin) | ehrlich ascites tumor | Resistant | High | 21899346 | |
| miR-183 | Doxorubicin (Adriamycin) | ehrlich ascites tumor | Resistant | High | 21899346 | |
| miR-128 | Doxorubicin (Adriamycin) | breast tumor-initiating cells | Sensitive | Low | 21953503 | |
| miR-17-92 | Doxorubicin (Adriamycin) | mantle cell lymphoma | Resistant | Low | 22116552 | |
| miR-1915 | Doxorubicin (Adriamycin) | colorectal carcinoma | Sensitive | Low | 22121083 | |
| miR-128-2 | Doxorubicin (Adriamycin) | non-small-cell lung cancer | Resistant | Low | 22193543 | |
| miR-122 | Doxorubicin (Adriamycin) | cutaneous T-cell lymphoma | Resistant | Low | 22235305 | |
| miR-199a | Doxorubicin (Adriamycin) | ovarian cancer | Sensitive | Low | 22498306 | |
| miR-126 | Doxorubicin (Adriamycin) | non-small cell lung cancer | Sensitive | Low | 22510476 | |
| miR-199a | Doxorubicin (Adriamycin) | colorectal cancer | Sensitive | Low | 22903020 | |
| miR-137 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 23178914 | |
| miR-146a | Doxorubicin (Adriamycin) | hepatocellular cancer | Sensitive | High | 23229111 | |
| miR-146b | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23229111 | |
| miR-181a | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23229111 | |
| miR-181d | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23229111 | |
| miR-186* | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23229111 | |
| miR-1908 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23229111 | |
| miR-1915 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23229111 | |
| miR-193b* | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23229111 | |
| miR-194 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23229111 | |
| hsa-novel-miR-12 | Doxorubicin (Adriamycin) | hepatocellular cancer | Sensitive | High | 23359607 | |
| hsa-novel-miR-13 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| hsa-novel-miR-14 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| hsa-novel-mir-15 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| hsa-novel-miR-17 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| hsa-novel-miR-19 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| miR-1255a | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| miR-1269b | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| miR-1277 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| miR-1293 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| miR-139 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| miR-181a | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| miR-196a | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| miR-135 | Doxorubicin (Adriamycin) | cervical carcinoma, colon cancer | Sensitive | Low | 23438844 | |
| miR-138 | Doxorubicin (Adriamycin) | cervical carcinoma, colon cancer | Sensitive | Low | 23438844 | |
| miR-125b | Doxorubicin (Adriamycin) | ewing sarcoma | Resistant | Low | 23497288 | |
| miR-1224 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-1229 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-1238 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-1273d | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-129 | Doxorubicin (Adriamycin) | gastric cancer | Resistant | High | 23525256 | |
| miR-133b | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-190 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-197 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-195 | Doxorubicin (Adriamycin) | colon cancer | Sensitive | Low | 23526568 | |
| miR-128 | Doxorubicin (Adriamycin) | breast cancer | Resistant | Low | 23526655 | |
| miR-19a | Doxorubicin (Adriamycin) | gastric cancer | Resistant | Low | 23603256 | |
| miR-19b | Doxorubicin (Adriamycin) | gastric cancer | Resistant | Low | 23603256 | |
| miR-1291 | Doxorubicin (Adriamycin) | - | Sensitive | Low | 23686318 | |
| miR-195 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 23760062 | |
| miR-106a | Doxorubicin (Adriamycin) | gastric cancer | Resistant | Low | 23932924 | |
| miR-137 | Doxorubicin (Adriamycin) | neuroblastoma | Sensitive | Low | 23934188 | |
| miR-133a | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 23969999 | |
| miR-196a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 23994196 | |
| miR-149 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 24007627 | |
| miR-187 | Doxorubicin (Adriamycin) | peripheral T-cell lymphoma | Resistant | Low | 24104394 | |
| miR-101 | Doxorubicin (Adriamycin) | hepatocellular carcinoma | Sensitive | Low | 24211739 | |
| miR-1269 | Doxorubicin (Adriamycin) | chronic myelogenous leukemia | Resistant | High | 24303078 | |
| miR-127 | Doxorubicin (Adriamycin) | chronic myelogenous leukemia | Sensitive | High | 24303078 | |
| miR-135b | Doxorubicin (Adriamycin) | chronic myelogenous leukemia | Resistant | High | 24303078 | |
| miR-146a | Doxorubicin (Adriamycin) | chronic myelogenous leukemia | Resistant | High | 24303078 | |
| miR-149 | Doxorubicin (Adriamycin) | chronic myelogenous leukemia | Resistant | High | 24303078 | |
| miR-184 | Doxorubicin (Adriamycin) | chronic myelogenous leukemia | Resistant | High | 24303078 | |
| miR-146a | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 24314246 | |
| miR-146b | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 24314246 | |
| miR-15a | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 24314246 | |
| miR-16 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 24314246 | |
| miR-181a | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 24314246 | |
| miR-181d | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 24314246 | |
| miR-194 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 24314246 | |
| miR-181a | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 24335172 | |
| miR-16 | Doxorubicin (Adriamycin) | lung adenocarcinoma | Sensitive | Low | 24462518 | |
| miR-100 | Doxorubicin (Adriamycin) | small cell lung cancer | Resistant | Low | 24559685 | |
| miR-100 | Doxorubicin (Adriamycin) | breast cancer | Resistant | Low | 24740415 | |
| miR-17 | Doxorubicin (Adriamycin) | breast cancer | Resistant | Low | 24740415 | |
| miR-181b | Doxorubicin (Adriamycin) | acute myeloid leukemia | Sensitive | Low | 24756163 | |
| miR-100 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | Low | 24759738 | |
| miR-1246 | Doxorubicin (Adriamycin) | gastric cancer | Resistant | High | 24759738 | |
| miR-125a | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | Low | 24759738 | |
| miR-1273g | Doxorubicin (Adriamycin) | gastric cancer | Resistant | Low | 24759738 | |
| miR-148a | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 24759738 | |
| miR-181a | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | Low | 24759738 | |
| miR-181b | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 24759738 | |
| miR-185 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | Low | 24763054 | |
| miR-130a | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 24788655 | |
| miR-1236 | Doxorubicin (Adriamycin) | diffuse large B cell lymphoma (DLBCL) | Resistant | High | 24858372 | |
| miR-1256 | Doxorubicin (Adriamycin) | diffuse large B cell lymphoma (DLBCL) | Resistant | High | 24858372 | |
| miR-129 | Doxorubicin (Adriamycin) | diffuse large B cell lymphoma (DLBCL) | Sensitive | High | 24858372 | |
| miR-138-1* | Doxorubicin (Adriamycin) | diffuse large B cell lymphoma (DLBCL) | Resistant | High | 24858372 | |
| miR-187 | Doxorubicin (Adriamycin) | diffuse large B cell lymphoma (DLBCL) | Resistant | High | 24858372 | |
| miR-191* | Doxorubicin (Adriamycin) | diffuse large B cell lymphoma (DLBCL) | Resistant | High | 24858372 | |
| miR-17 | Doxorubicin (Adriamycin) | synovial sarcoma | Resistant | Low | 24989082 | |
| miR-155 | Doxorubicin (Adriamycin) | osteosarcoma | Sensitive | Low | 25009614 | |
| miR-101 | Doxorubicin (Adriamycin) | osteosarcoma | Resistant | Low | 25013866 | |
| miR-149 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 25156775 | |
| miR-135a | Doxorubicin (Adriamycin) | gastric cancer | Resistant | Low | 25322930 | |
| miR-16 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | Low | 25327162 | |
| miR-129 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | Low | 25344911 | |
| miR-103 | Doxorubicin (Adriamycin) | gastric carcinoma | Sensitive | Low | 25407491 | |
| miR-107 | Doxorubicin (Adriamycin) | gastric carcinoma | Sensitive | Low | 25407491 | |
| miR-10a | Doxorubicin (Adriamycin) | gastric cancer | Resistant | High | 25407491 | |
| miR-1224 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 25407491 | |
| miR-1254 | Doxorubicin (Adriamycin) | gastric cancer | Resistant | High | 25407491 | |
| miR-145 | Doxorubicin (Adriamycin) | gastric cancer | Resistant | High | 25407491 | |
| miR-17 | Doxorubicin (Adriamycin) | gastric cancer | Resistant | High | 25407491 | |
| miR-125-1 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 25451164 | |
| miR-141 | Doxorubicin (Adriamycin) | breast cancer | Resistant | Low | 25451164 | |
| miR-145 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 25451164 | |
| miR-196b | Doxorubicin (Adriamycin) | breast cancer | Resistant | Low | 25451164 | |
| miR-193a | Doxorubicin (Adriamycin) | bladder cancer | Resistant | Low | 25542424 | |
| miR-125b | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 25562151 | |
| miR-145 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 25562151 | |
| miR-152 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 25562151 | |
| miR-155 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 25562151 | |
| miR-181a | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 25562151 | |
| miR-193b | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 25562151 | |
| miR-143 | Doxorubicin (Adriamycin) | osteosarcoma | Sensitive | Low | 25576341 | |
| miR-10a | Doxorubicin (Adriamycin) | acute myeloid leukemia | Resistant | Low | 25687041 | |
| miR-101 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-10a* | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-1226 | Doxorubicin (Adriamycin) | liver cancer | Sensitive | High | 25698578 | |
| miR-1226* | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-1228* | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-1233 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-1234 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-124 | Doxorubicin (Adriamycin) | liver cancer | Sensitive | High | 25698578 | |
| miR-1253 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-1265 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-127 | Doxorubicin (Adriamycin) | liver cancer | Sensitive | High | 25698578 | |
| miR-129 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-1299 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-137 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-138 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-139 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-140 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-148a | Doxorubicin (Adriamycin) | liver cancer | Sensitive | High | 25698578 | |
| miR-1538 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-1539 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-15a* | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-17* | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-183 | Doxorubicin (Adriamycin) | liver cancer | Sensitive | High | 25698578 | |
| miR-185 | Doxorubicin (Adriamycin) | liver cancer | Sensitive | High | 25698578 | |
| miR-18b | Doxorubicin (Adriamycin) | liver cancer | Sensitive | High | 25698578 | |
| miR-1911 | Doxorubicin (Adriamycin) | liver cancer | Sensitive | High | 25698578 | |
| miR-1911* | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-1915 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-1915* | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-193b | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-133a | Doxorubicin (Adriamycin) | hepatocellular carcinoma | Sensitive | Low | 25714665 | |
| miR-1291 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 25934574 | |
| miR-1291 | Doxorubicin (Adriamycin) | pancreatic carcinoma | Sensitive | Low | 25934574 | |
| miR-125b-1 | Doxorubicin (Adriamycin) | neuroblastoma | Sensitive | High | 25973145 | |
| miR-125b-1 | Doxorubicin (Adriamycin) | neuroblastoma | Sensitive | High | 25973145 | |
| miR-150 | Doxorubicin (Adriamycin) | neuroblastoma | Resistant | High | 25973145 | |
| miR-150 | Doxorubicin (Adriamycin) | neuroblastoma | Resistant | High | 25973145 | |
| miR-188 | Doxorubicin (Adriamycin) | neuroblastoma | Resistant | High | 25973145 | |
| miR-188 | Doxorubicin (Adriamycin) | neuroblastoma | Resistant | High | 25973145 | |
| miR-199a | Doxorubicin (Adriamycin) | osteosarcoma | Resistant | Low | 26079799 | |
| miR-124 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 26115122 | |
| miR-124 | Doxorubicin (Adriamycin) | osteosarcoma | Sensitive | Low | 26115122 | |
| miR-199a | Doxorubicin (Adriamycin) | diffuse large B-cell lymphoma | Sensitive | Low | 26251897 | |
| miR-127 | Doxorubicin (Adriamycin) | glioma | Resistant | Low | 26261488 | |
| miR-134 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 26318721 | |
| miR-193b | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 26526790 | |
| miR-101 | Doxorubicin (Adriamycin) | hepatocellular carcinoma | Sensitive | Low | 26718267 |